173 related articles for article (PubMed ID: 28396344)
1. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury.
Poppelaars F; van Werkhoven MB; Kotimaa J; Veldhuis ZJ; Ausema A; Broeren SGM; Damman J; Hempel JC; Leuvenink HGD; Daha MR; van Son WJ; van Kooten C; van Os RP; Hillebrands JL; Seelen MA
FASEB J; 2017 Jul; 31(7):3193-3204. PubMed ID: 28396344
[TBL] [Abstract][Full Text] [Related]
2. Enhanced activation of interleukin-10, heme oxygenase-1, and AKT in C5aR2-deficient mice is associated with protection from ischemia reperfusion injury-induced inflammation and fibrosis.
Thorenz A; Derlin K; Schröder C; Dressler L; Vijayan V; Pradhan P; Immenschuh S; Jörns A; Echtermeyer F; Herzog C; Chen R; Rong S; Bräsen JH; van Kooten C; Kirsch T; Klemann C; Meier M; Klos A; Haller H; Hensen B; Gueler F
Kidney Int; 2018 Oct; 94(4):741-755. PubMed ID: 29935951
[TBL] [Abstract][Full Text] [Related]
3. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
[TBL] [Abstract][Full Text] [Related]
4. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
5. The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita.
Seiler DL; Kähler KH; Kleingarn M; Sadik CD; Bieber K; Köhl J; Ludwig RJ; Karsten CM
Front Immunol; 2023; 14():1197709. PubMed ID: 37275893
[TBL] [Abstract][Full Text] [Related]
6. The C5a/C5aR2 axis promotes renal inflammation and tissue damage.
Zhang T; Wu KY; Ma N; Wei LL; Garstka M; Zhou W; Li K
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32191644
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
8. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
9. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
11. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
[TBL] [Abstract][Full Text] [Related]
12. Role of complement anaphylatoxin receptors in a mouse model of acute burn-induced pain.
Morgan M; Deuis JR; Woodruff TM; Lewis RJ; Vetter I
Mol Immunol; 2018 Feb; 94():68-74. PubMed ID: 29274925
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
Front Immunol; 2022; 13():942493. PubMed ID: 36466856
[TBL] [Abstract][Full Text] [Related]
14. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
15. The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production.
Pundir P; MacDonald CA; Kulka M
J Immunol; 2015 Sep; 195(6):2774-87. PubMed ID: 26283482
[TBL] [Abstract][Full Text] [Related]
16. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
Zhang K; Li GQ; He QH; Li Y; Tang M; Zheng QY; Xu GL; Zhang KQ
Int Immunopharmacol; 2017 Dec; 53():17-23. PubMed ID: 29031143
[TBL] [Abstract][Full Text] [Related]
17. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
[TBL] [Abstract][Full Text] [Related]
18. Complement receptors C5aR1 and C5aR2 act differentially during the early immune response after bone fracture but are similarly involved in bone repair.
Kovtun A; Bergdolt S; Hägele Y; Matthes R; Lambris JD; Huber-Lang M; Ignatius A
Sci Rep; 2017 Oct; 7(1):14061. PubMed ID: 29070810
[TBL] [Abstract][Full Text] [Related]
19. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.
Zhang T; Garstka MA; Li K
J Immunol Res; 2017; 2017():8193932. PubMed ID: 28706957
[TBL] [Abstract][Full Text] [Related]
20. Monitoring C5aR2 Expression Using a Floxed tdTomato-C5aR2 Knock-In Mouse.
Karsten CM; Wiese AV; Mey F; Figge J; Woodruff TM; Reuter T; Scurtu O; Kordowski A; Almeida LN; Briukhovetska D; Quell KM; Sun J; Ender F; Schmudde I; Vollbrandt T; Laumonnier Y; Köhl J
J Immunol; 2017 Nov; 199(9):3234-3248. PubMed ID: 28864475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
